Preferred Name | OL(1)p53 | |
Synonyms |
|
|
ID |
http://purl.bioontology.org/ontology/MESH/C086760 |
|
cui |
C0700610 |
|
HM |
D013873 |
|
Inverse of RB |
CI002S7WH8 |
|
Mapped to | ||
MDA |
19940513 |
|
MeSH Frequency |
4 |
|
MMR |
20181210 |
|
notation |
C086760 |
|
PI |
*OLIGONUCLEOTIDES, ANTISENSE (94-98) *OLIGODEOXYNUCLEOTIDES, ANTISENSE (1999-2007) |
|
prefLabel |
OL(1)p53 |
|
SC |
1 |
|
Scope Statement |
a 20-mer synthetic phosphorothioate oligonucleotide with a sequence complementary to p53; used in Phase I clinical trial for the treatment of acute myelogenous leukemia (AML) and myelodysplastic syndrome (MDS) |
|
SRC |
Antisense Res Dev 1993 Winter;3(4):383-90 |
|
TERMUI |
T259977 |
|
TH |
NLM (1994) |
|
tui |
T114 T121 |
Create mapping
Delete | Mapping To | Ontology | Source |
---|---|---|---|
http://purl.bioontology.org/ontology/PDQ/CDR0000041871 | PDQ | CUI | |
http://purl.bioontology.org/ontology/PDQ/CDR0000354249 | PDQ | CUI | |
http://phenomebrowser.net/ontologies/mesh/mesh.owl#C086760 | RH-MESH | LOOM |